Emerald Ventures

Emerald Ventures, a venture capital firm founded by seasoned entrepreneurs, focuses on investing in early-stage technology companies with the potential for exponential growth. With a laser focus on disruptive industries such as fintech and health tech, Emerald Ventures has a proven track record of identifying and backing innovative startups that are poised to revolutionize their respective markets. Their portfolio boasts successful investments in companies like Robinhood, a commission-free stock trading platform, and 23andMe, a consumer genetics company that provides personalized health reports.

Emerald Ventures' investment strategy centers around providing capital and strategic guidance to founders who are building game-changing technology companies. They typically invest in companies at the seed or Series A stage, with ticket sizes ranging from $500,000 to $5 million. By leveraging their extensive network, industry expertise, and hands-on approach, Emerald Ventures helps portfolio companies navigate the challenges of scaling their businesses and achieving market dominance. With a keen eye for identifying disruptive trends and a passion for supporting visionary founders, Emerald Ventures is at the forefront of driving innovation in the startup ecosystem.